CPHI vs BIOA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

CPHI

53.4
AI Score
VS
CPHI Wins

BIOA

46.6
AI Score

Investment Advisor Scores

CPHI

53score
Recommendation
HOLD

BIOA

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CPHI BIOA Winner
Forward P/E 1.5581 0 Tie
PEG Ratio 0.1558 0 Tie
Revenue Growth -7.5% 1.6% BIOA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 53.4/100 46.6/100 CPHI
Profit Margin -114.3% 0.0% BIOA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CPHI 1M: -27.7% · 3M: -50.2% BIOA 1M: +5.4% · 3M: -43.7%

Current Technical Phase

CPHI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.9%), weak momentum, RSI 35

RSI (14): 34.6 · Price: $0.54

BIOA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.5 · Price: $5.87

Fundamentals Snapshot

Metric CPHI BIOA
Market Cap — —
Forward P/E 1.6 -2.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% -0.9%
Gross Margin 0.1% -10.6%
Operating Margin -1.5% -125.5%
EPS -0.42 -2.56
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CPHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.